4.6 Article

Clinical validation of the Siemens quantitative SARS-CoV-2 spike IgG assay (sCOVG) reveals improved sensitivity and a good correlation with virus neutralization titers

Related references

Note: Only part of the references are listed.
Article Pathology

Differences in Performance Characteristics Among Four High-Throughput Assays for the Detection of Antibodies Against SARS-CoV-2 Using a Common Set o Patient Samples

David M. Manthei et al.

Summary: With the passage of time from symptom onset, samples from SARS-CoV-2 RT-PCR-positive patients showed increasing positivity. The sensitivity of EUROIMMUN, Roche, and Siemens assays reached 93.1% to 96.6%, 98.3%, and 96.6%, respectively, for patients with the latest sample collected 14 or more days after symptom onset, outperforming the DiaSorin assay at 87.7%. The specificity of Roche and Siemens assays was 100%, higher than DiaSorin and EUROIMMUN assays.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2021)

Review Biochemistry & Molecular Biology

COVID-19 vaccines: where we stand and challenges ahead

Guido Forni et al.

Summary: The development of vaccines has made significant progress, but still faces various challenges, including different target populations, immunological adaptability of vaccines, and production and distribution issues. To ensure equitable access, protection of diverse subjects, and immunity against viral variants, multiple vaccines may be needed in the long run.

CELL DEATH AND DIFFERENTIATION (2021)

Article Respiratory System

Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial

Thomas Sonnweber et al.

Summary: A study found that some COVID-19 patients still experienced persistent symptoms and lung function impairment 100 days after the onset of the disease, but there was significant improvement in symptoms and cardiopulmonary status over time.

EUROPEAN RESPIRATORY JOURNAL (2021)

Article Microbiology

Multicenter Evaluation of the Clinical Performance and the Neutralizing Antibody Activity Prediction Properties of 10 High-Throughput Serological Assays Used in Clinical Laboratories

C. Therrien et al.

Summary: As the second wave of the COVID-19 pandemic emerges, screening population immunity is crucial to track infected individuals. Accumulating data on immune responses and nAb production in SARS-CoV-2-infected individuals will lead to new applications for serological assays. This study evaluated the clinical performances, reproducibility, and nAb level correlations of 10 immunoassays, with spike-based immunoassays showing better correlates of nAb activity.

JOURNAL OF CLINICAL MICROBIOLOGY (2021)

Article Medicine, General & Internal

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey et al.

Summary: The ChAdOx1 nCoV-19 vaccine has been shown to have an acceptable safety profile and effectiveness against symptomatic COVID-19, with higher efficacy observed in the group that received a low dose followed by a standard dose.

LANCET (2021)

Article Immunology

Comparison of Four SARS-CoV-2 Neutralization Assays

Lydia Riepler et al.

Summary: Neutralizing antibodies are crucial for protection against viruses like SARS-CoV-2. This study compared four different assays for detecting these antibodies and found that they were all robust and yielded comparable results, indicating their reliability.

VACCINES (2021)

Article Immunology

Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Katharine H. D. Crawford et al.

Summary: Antibody levels, including neutralizing antibodies, decline after SARS-CoV-2 infection, with a 4-fold average decrease in titers from 1 to 4 months after symptom onset. This decline is accompanied by a decrease in total antibodies capable of binding the viral spike protein. Further studies are needed to determine the long-term durability of immunity to SARS-CoV-2, including examination of long-lived B cells and antibody titers over extended periods.

JOURNAL OF INFECTIOUS DISEASES (2021)

Article Medicine, General & Internal

Clinical Characteristics of Coronavirus Disease 2019 in China

W. Guan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

A Novel Coronavirus from Patients with Pneumonia in China, 2019

Na Zhu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Pathology

SARS-CoV-2 Antibody Responses Do Not Predict COVID-19 Disease Severity

William S. Phipps et al.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2020)

Article Medical Laboratory Technology

Side-by-Side Comparison of Three Fully Automated SARS-CoV-2 Antibody Assays with a Focus on Specificity

Thomas Perkmann et al.

CLINICAL CHEMISTRY (2020)

Article Biochemistry & Molecular Biology

Biochemical characterization of SARS-CoV-2 nucleocapsid protein

Weihong Zeng et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)

Article Medicine, General & Internal

Prevalence and Predictive Value of Anemia and Dysregulated Iron Homeostasis in Patients with COVID-19 Infection

Rosa Bellmann-Weiler et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Article Virology

Quantification of SARS-CoV-2 antibodies with eight commercially available immunoassays

Lisa Weidner et al.

JOURNAL OF CLINICAL VIROLOGY (2020)

Article Medicine, General & Internal

An mRNA Vaccine against SARS-CoV-2-Preliminary Report

L. A. Jackson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medical Laboratory Technology

Evaluation of three fully-automated SARS-CoV-2 antibody assays

Sebastian Hoerber et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)

Article Medicine, Research & Experimental

Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population

Sabra Klein et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Article Medicine, General & Internal

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

Edward E. Walsh et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

News Item Critical Care Medicine

The Russian vaccine for COVID-19

Talha Khan Burki

LANCET RESPIRATORY MEDICINE (2020)

Article Medicine, Research & Experimental

Convalescent plasma anti SARS-CoV-2 spike protein ectodomain and receptor-binding domain IgG correlate with virus neutralization

Eric Salazar et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Review Multidisciplinary Sciences

Antibody response to SARS-CoV-2 infection in humans: A systematic review

Nathan Post et al.

PLOS ONE (2020)

Article Biotechnology & Applied Microbiology

Temporal Course of SARS-CoV-2 Antibody Positivity in Patients with COVID-19 following the First Clinical Presentation

Martin Risch et al.

BIOMED RESEARCH INTERNATIONAL (2020)

Article Medicine, General & Internal

Dynamics of CD4 T Cell and Antibody Responses in COVID-19 Patients With Different Disease Severity

Maximilian Koblischke et al.

FRONTIERS IN MEDICINE (2020)

Article Biochemistry & Molecular Biology

Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19

Xiangyu Chen et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Letter Immunology

Patterns of IgG and IgM antibody response in COVID-19 patients

Xuemei Liu et al.

EMERGING MICROBES & INFECTIONS (2020)